bibliographic entry 8105545 [be/8105545]
https://w3id.org/oc/corpus/be/8105545

is a
content
  • Orlowski RZ, Nagler A, Sonneveld P, Blade J, Hajek R, Spencer A et al. Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression. J Clin Oncol 2007; 25: 3892–3901. PMID: 17679727
references